Clinical Trial Update: Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low-dose landiolol to prevent atrial fibrillation after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• LANdiolol (landiolol hydrochloride)

Snippet

Sponsor: CMC Ambroise Paré | Conditions: Atrial Fibrillation, Cardiac Surgery | Phase 3 | Status: COMPLETED